Azithromycin and Risk of Deadly Irregular Heart Rhythm
RxEconsult, LLC
2013
- 4Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage4
- Abstract Views4
Blog Post Description
Azithromycin, a commonly-prescribed antibiotic, may trigger a potentially deadly irregular heart rhythm for some patients, the Food and Drug Administration (FDA) warned Tuesday. Azithromycin sold as Zithromax, Zmax or sometimes referred to as a "Z-Pack" is prescribed to treat bacterial infections such as bronchitis, pneumonia, or ear infections. The FDA is warning the public that the pills can cause abnormal changes in the heart's electrical activity that may lead to a fatal heart rhythm. This warning is based on findings from a study that compared the risk of death from heart related effects of azithromycin, levofloxacin, ciprolfloxacin, and amoxicillin. After 5 days of treatment, the risk of heart related death in patients treated with azithromycin was significantly greater than those who did not receive antibiotic and those treated with amoxicillin or ciprofloxacin.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know